"I am glad that taking part in a trial might help others on their own cancer journey.”
A study looking at enzymes and genes to help doctors work out who is likely to have more severe side effects with chemotherapy
Cancer type:
All cancer types
Status:
Results
Phase:
Pilot
This study was done to try to find out more about an enzyme in the blood called CDA. This may be linked to whether or not you have severe side effects from some chemotherapy drugs.
All drugs used to treat cancer cause side effects. Different drugs have different side effects. People vary in the side effects they have and in how severe they are. Some people have only very mild side effects.
In this study, researchers were looking at an 
called CDA. We know from research that there is a link between the amount of CDA in the plasma and the side effects people have with some chemotherapy drugs. The study team wanted to look at CDA and genes in samples of blood from people with cancer who had never had chemotherapy.
They hoped to develop ways of measuring in advance how treatment side effects may affect people.
Summary of results
This study was never finished so there are no results available. The researchers were unable to recruit enough patients.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Professor Alan Boddy
Supported by
Experimental Cancer Medicine Centre (ECMC)
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Freephone 0808 800 4040
Last review date
CRUK internal database number:
Oracle 9647
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Cara took part in a clinical trial
